These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 7541605

  • 1. Use of 2-chlorodeoxyadenosine, granulocyte-colony-stimulating factor, and erythropoietin in a Jehovah's Witness with hairy cell leukemia.
    Couban S, Wilson WE.
    Am J Hematol; 1995 Jul; 49(3):255-6. PubMed ID: 7541605
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of hair cell leukemia with 2-chlorodeoxyadenosine and G-CSF].
    Bengió R, Pérez M, Sarmiento M, Raña P, Sánchez Lucero A, Sarto A, Arrossagaray G.
    Medicina (B Aires); 1996 Jul; 56(5 Pt 1):534. PubMed ID: 9239892
    [No Abstract] [Full Text] [Related]

  • 3. Successful treatment of acute promyelocytic leukemia in a pregnant Jehovah's Witness with all-trans retinoic acid, rhG-CSF, and erythropoietin.
    Lin CP, Huang MJ, Liu HJ, Chang IY, Tsai CH.
    Am J Hematol; 1996 Mar; 51(3):251-2. PubMed ID: 8619417
    [No Abstract] [Full Text] [Related]

  • 4. Successful use of recombinant human erythropoietin in a Jehovah's Witness with a thermal injury.
    Deitch EA, Guillory D, Cruz N.
    J Burn Care Rehabil; 1994 Mar; 15(1):42-5. PubMed ID: 8150842
    [Abstract] [Full Text] [Related]

  • 5. Mortality risk stratification in severely anaemic Jehovah's Witness patients.
    Beliaev AM, Marshall RJ, Smith W, Windsor JA.
    Intern Med J; 2012 Mar; 42(3):e1-3. PubMed ID: 22432994
    [Abstract] [Full Text] [Related]

  • 6. The use of interferon-alpha and granulocyte colony-stimulating factor in hairy cell leukaemia with aplastic marrow.
    Osterholz J, Wohlleber M, Kahnt C, Schumacher K.
    Eur J Haematol; 1995 Aug; 55(2):140-2. PubMed ID: 7543058
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Recombinant human erythropoietin for a Jehovah's Witness with anemia of thermal injury.
    Boshkov LK, Tredget EE, Janowska-Wieczorek A.
    Am J Hematol; 1991 May; 37(1):53-4. PubMed ID: 2024641
    [Abstract] [Full Text] [Related]

  • 9. The optimal management of hairy cell leukaemia.
    Gollard R, Lee TC, Piro LD, Saven A.
    Drugs; 1995 Jun; 49(6):921-31. PubMed ID: 7543840
    [Abstract] [Full Text] [Related]

  • 10. Use of recombinant human erythropoietin in a Jehovah's Witness.
    Koenig HM, Levine EA, Resnick DJ, Meyer WJ.
    J Clin Anesth; 1993 Jun; 5(3):244-7. PubMed ID: 8318245
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of perioperative acute anemia by human recombinant erythropoietin in a Jehovah's witness].
    Boursas M, Benhassine L, Paris F, Kempf J, Vuillemin F.
    Ann Fr Anesth Reanim; 1997 Jun; 16(3):312-3. PubMed ID: 9732784
    [No Abstract] [Full Text] [Related]

  • 12. [Failure of treatment with 2-chlorodeoxyadenosine in the course of hairy cell leukemia associated with malignant histiocytosis].
    Jullien V, Peyrade F, Taillan B, Perrin C, Sanderson F, Guzman-Granier E, Michiels JF, Dujardin P.
    Rev Med Interne; 1999 Mar; 20(3):287-8. PubMed ID: 10216890
    [No Abstract] [Full Text] [Related]

  • 13. [2-chlorodeoxyadenosine (2-CdA) cladribine therapy in hairy cell leukemia].
    Raanani P, Shpilberg O, Ben-Bassat I.
    Harefuah; 1994 Jun 01; 126(11):673-6. PubMed ID: 7927005
    [No Abstract] [Full Text] [Related]

  • 14. Growth factors and HIV-infection in children.
    Zuccotti GV, Flumine P, Locatelli V, Banderali G, Riva E.
    J Int Med Res; 1993 Jun 01; 21(6):342-5. PubMed ID: 7511543
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pegfilgrastim prophylaxis for cladribine-induced neutropenia in patients with hairy-cell leukemia.
    Goldschmidt N, Ganzel C, Attias D, Gatt M, Polliack A, Tadmor T.
    Acta Haematol; 2014 Jun 01; 132(1):118-21. PubMed ID: 24557414
    [No Abstract] [Full Text] [Related]

  • 17. Erythropoietin use in a Jehovah's Witness patient.
    Walton T, Macon EJ.
    Ann Pharmacother; 2002 Apr 01; 36(4):729-30. PubMed ID: 11936087
    [No Abstract] [Full Text] [Related]

  • 18. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor (rhG-CSF) and erythropoietin (rhEpo) in severe aplastic anaemia.
    Bessho M, Toyoda A, Itoh Y, Sakata T, Kawai N, Jinnai I, Saito M, Hirashima K.
    Br J Haematol; 1992 Mar 01; 80(3):409-11. PubMed ID: 1374630
    [No Abstract] [Full Text] [Related]

  • 19. The development of congestive cardiac failure in a patient with hairy cell leukemia treated with 2-chlorodeoxyadenosine.
    Koczwara B, Spangenthal E, Bernstein SH.
    Leuk Lymphoma; 1997 Jul 01; 26(3-4):413-5. PubMed ID: 9322907
    [Abstract] [Full Text] [Related]

  • 20. Cladribine (2-chlorodeoxyadenosine) therapy in hairy cell leukemia variant. A report of three cases.
    Palomera L, Domingo JM, Sola C, Azaceta G, Calvo MT, Gutierrez M.
    Haematologica; 2002 Jan 01; 87(1):107-8. PubMed ID: 11801472
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.